The Relationship between Risk Factors for Metabolic Syndrome and Bone Mineral Density in Menopausal Korean Women
Background: The risk factors of metabolic syndrome (MetS) in menopausal women are potential causes of osteoporosis. However, there is no consensus on this. We aimed to determine the relationship between risk factors of MetS and bone mineral density (BMD) in menopausal Korean women.
Methods: We enrolled 205 menopausal Korean women who visited a health promotion center in Seoul in 2015 and divided them into the following two groups according to the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III) criteria with modified waist-circumference criteria: the non-MetS group (Group 1, n=90) and the MetS group (Group 2, n=115). Anthropometric parameters and clinical parameters, including blood pressure, blood lipid profile (cholesterol, triglycerides), and fasting blood sugar levels were recorded for all participants. BMD at the lumbar spine was determined using dual-energy X-ray absorptiometry (DEXA). The relationship between the risk factors of MetS and bone mineral density was analyzed by statistical methods.
Results: There was no significant difference in risk factors of MetS between the groups. In correlation tests, waist circumference showed a significant association with body surface area (BSA) (r = -0.242, P < 0.001). Diastolic blood pressure was correlated with BSA (r = 0.186, P < 0.01) and bone mineral content (BMC) (r = 0.161, P < 0.05). However, multiple regression analysis showed no significant relationship between MetS risk factors and BMD.
Conclusion: The risk factors of MetS did not affect BMD in menopausal Korean women. Follow-up studies with a larger study population are necessary size to allow the investigation of other research variables.
2. Iglseder B, Cip P, Malaimare L, et al (2005). The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke, 36:1212-1217.
3. Carr MC, Kim KH, Zambon A, et al (2000). Changes in LDL density across the menopausal transition. J Investig Med, 48:245-250.
4. Zhou L, Song J, Yang S, et al (2017). Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study. Osteoporos Int, 28:1693-1698.
5. Lerner UH (2006). Bone remodeling in post-menopausal osteoporosis. J Dent Res, 85:584-595.
6. Ji MX, Yu Q (2015). Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med, 1:9-13.
7. Gambacciani M, Vacca F (2004). Postmenopausal osteoporosis and hormone replacement therapy. Minerva Med, 95:507-520.
8. Kim KC, Shin DH, Lee SY, et al (2010). Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Med J, 51:857-863.
9. Wong SK, Chin KY, Suhaimi FH, et al (2016). The relationship between metabolic syndrome and osteoporosis: a review. Nutrients, 8(6):pii:E347.
10. da Silva VN, Fiorelli LN, da Silva CC, et al (2017). Do metabolic syndrome and its components have an impact on bone mineral density in adolescents? Nutr Metab (Lond). 14:1.
11. McFarlane SI (2006). Bone metabolism and the cardiometabolic syndrome: pathophysiologic insights. J Cardiometab Syndr, 1:53-57.
12. Bredella MA, Gill CM, Gerweck AV, et al (2013). Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology, 269:534-541..
13. Abbasi M, Farzam SA, Mamaghani Z, et al (2017). Relationship between metabolic syndrome and its components with bone densitometry in postmenopausal women. Diabetes Metab Syndr, 11(Suppl 1):S73-S76.
14. Caglayan EK, Engin-Ustun Y, Sari N, et al (2015). Evaluation of bone density measurement in type 2 diabetic postmenopausal women with hypertension and hyperlipidemia. J Menopausal Med, 21:36-40.
15. Indhavivadhana S, Rattanasrithong P (2015). The relationship between bone mineral density and metabolic syndrome in peri- and post-menopausal Thai women. Arch Gynecol Obstet, 292:1127-1133.
16. Zanatta LCB, Boguszewski CL, Borba VZ, et al (2018). Association between undercarboxylated osteocalcin, bone mineral density, and metabolic parameters in postmenopausal women. Arch Endocrinol Metab, 62:446-451.
17. Ozelci R, Dilbaz B, Ozkaya E, et al (2016). Association between bone mineral density and metabolic syndrome in Turkish women who were postmenopausal. Int J Gynaecol Obstet, 133:370-374.
18. Park KK, Kim SJ, Moon ES (2010). Association between bone mineral density and metabolic syndrome in postmenopausal Korean women. Gynecol Obstet Invest, 69:145-152.
19. De Laet C, Kanis JA, Odén A, et al (2005). Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int, 16:1330-1338.
20. El Maghraoui A, Rezqi A, El Mrahi S, et al (2014). Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women. BMC Endocr Disord, 14:93.
21. von Muhlen D, Safii S, Jassal SK, et al (2007). Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int, 18:1337-1344.
22. Shin CS, Choi HJ, Kim MJ, et al (2010). Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density. Bone, 47:378-387.
23. Manocha A, Srivastava LM, Bhargava S (2017). Lead as a risk factor for osteoporosis in post-menopausal women. Indian J Clin Biochem, 32:261-265.
24. Jeon YJ, Kim JW, Park JS (2014). Factors associated with the treatment of osteoporosis in Korean postmenopausal women. Women Health, 54:48-60.
25. Shin MS, Cho EH, Kim HY (2017). Longitudinal change in trabecular bone score during and after treatment of osteoporosis in postmenopausal Korean women. J Bone Metab, 24:117-124.
26. Grundy SM, Cleeman JI, Daniels SR, et al (2005). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112:2735-2752.
27. Aye M, Sazali M (2012). Waist circumference and BMI cut-off points to predict risk factors for metabolic syndrome among outpatients in a district hospital. Singapore Med J, 53:545-550.
28. Sözen T, Özışık L, Başaran NÇ (2017). An overview and management of osteoporosis. Eur J Rheumatol, 4:46-56.
29. Bridges MJ, Ruddick S (2011). Are metatarsal fractures indicative of osteoporosis in postmenopausal women? Foot Ankle Spec, 4:271-273.
30. Cui LH, Shin MH, Chung EK, et al (2005). Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea. Osteoporos Int, 16:1975-1981.
31. Massé PG, Tranchant CC, Dosy J, et al (2005). Coexistence of osteoporosis and cardiovascular disease risk factors in apparently healthy, untreated postmenopausal women. Int J Vitam Nutr Res, 75:97-106.
32. Pekcan MK, Findik RB, Tokmak A, et al (2018). The relationship between breast density, bone mineral density, and metabolic syndrome among postmenopausal Turkish women. J Clin Densitom, 2018 Nov 8. pii:S1094-6950(18)30185-9. [Epub ahead of print].
33. Kim BJ, Ahn SH, Bae SJ, et al (2013). Association between metabolic syndrome and bone loss at various skeletal sites in postmenopausal women: a 3-year retrospective longitudinal study. Osteoporos Int, 24:2243-2252.
34. Zengin A, Prentice A, Ward KA (2015). Ethnic differences in bone health. Front Endocrinol (Lausanne). 6:24.
35. El Maghraoui A, Koumba BA, Jroundi I, et al (2005). Epidemiology of hip fractures in 2002 in Rabat, Morocco. Osteoporos Int, 16:597-602.
36. Sadat-Ali M, Al-Habdan IM, Al-Mulhim FA, et al (2004). Bone mineral density among postmenopausal Saudi women. Saudi Med J, 25:1623-1625.
|Issue||Vol 48 No 6 (2019)|
|Bone mineral density menopausal women Metabolic Syndrome osteoporosis Korea|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|